Timber Pharmaceuticals Inc.

(NYSE: TMBR)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis, facial angiofibromas in tuberous sclerosis complex, and scleroderma. The company's development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A Receptor Antagonist).

Contact Information

Website: www.timberpharma.com
Email: info@timberpharma.com
Main Phone: +1 914 205-3481
Address: 110 Allen Road
Address 2: Suite 401
State: NJ
City / Town: Basking Ridge
Country: US
Postal Code: 07920

Issuer Information

Exchange: AMX
CEO: John Koconis
Employees: 6
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A